| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers U > Headlines for U.S. Renal Care Inc. > News item |
S&P rates U.S. Renal loan B+
Standard & Poor's said that it affirmed the B corporate credit rating on U.S. Renal Care Inc. and assigned a B+ rating with a 2 recovery, indicating substantial 970%-90%) recovery, to the company's proposed $40 million revolving credit facility and $215 million first-lien term loan .
The ratings reflect the company's highly leveraged financial risk profile and vulnerable business risk profile, the agency said.
The company's single-focus business is relatively small, with limited geographic diversity, the agency added.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.